Sreyashi Basu

26PUBLICATIONS

215CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursInnate immunityGene and molecular therapyMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (26)

Sort by Publication Date:

|May 07, 2026

Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.

|Mar 10, 2026

Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma.

JongHoon Ha, Yifan Wang, Yifan Ma

|Jan 09, 2026

Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade.

Mehdi Chaib, Muhammad Aminu, Shelley Herbrich

|Oct 08, 2025

Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses.

Alexander L Ling, Jennifer Gantchev, Michael C Prabhu

|Sep 10, 2025

Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti-PD-1 therapy.

Jielin Liu, Shelley Herbrich, Sreyashi Basu

|Aug 20, 2025

Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy.

Erez N Baruch, Frederico O Gleber-Netto, Priyadharsini Nagarajan

Pageof 5

Frequent Collaborators

21 joint publications

Padmanee Sharma

13 joint publications

Sonali Jindal

9 joint publications

Sangeeta Goswami

7 joint publications

Rebecca Slack Tidwell

Andrew Futreal

Matthew T Campbell

Alexsandra B Espejo

Shalini Singh Yadav

James P Allison

Jianjun Gao

Frequent Collaborators

21 joint publications

Padmanee Sharma

13 joint publications

Sonali Jindal

9 joint publications

Sangeeta Goswami

7 joint publications

Rebecca Slack Tidwell